EATG » R&D

R&D

Making the European Patients’ Academy on Therapeutic Innovation sustainable

EFOEUPATI   The EATG is involved in the IMI-funded EFOEUPATI Project (Ensuring the Future of EUPATI - the European Patients’ Academy on Therapeutic Innovation) and especially in the work related…

UK, Germany, dissociate from WHO drug pricing resolution

The passage of a landmark resolution on improving the transparency of markets for medicines at the latest WHA fails to narrow the political divide. John Zarocostas reports from Geneva. Few…

Incentives for EU pharmaceutical R&D – new review

A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. The briefing series was…

World Health Assembly approves milestone resolution on price transparency

28 May 2019: The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series…

Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure

A closed-door group of negotiators reached agreement late Monday (May 27) evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs…

Future of drug pricing resolution hangs in balance at World Health Assembly

23 May: The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the…

Smarter research & development to tackle global health priorities

Today, May 15, WHO’s new Science Division launched an online resource to guide the development of new health products for which there are limited markets or incentives for research and…

Health Policy Watch makes latest text of WHO transparency resolution open access

Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all,…

Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access

Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects…

Several developed countries want to “derail” transparency resolution – civil society groups say

More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the…

1 2 3 8